Expand Healthcare Consulting  GmbH

Point of Care In Vitro Diagnostics Experts

Expand Healthcare Consulting GmbH

Point of Care In Vitro Diagnostics Experts

Expand Healthcare support KDx Acceleration with the cMyC Cardiac Biomarker launch

Expand Healthcare Consulting, cMyC release following cardiac surgical interventions

cMyC is a rapid cardiac specific biomarker

Expand Healthcare Consulting is supporting KDx Acceleration with the launch of the cMyC cardiac biomarker. Expand have developed the cMyC biomarker website (www.cmycbiomarker.com) and are approaching POC IVD companies worldwide with interest to know more about this novel cardiac biomarker. 

cMyC (Cardiac Myosin-binding Protein C), also abbreviated as cMyBP-C, is a structural muscle protein contained within the contractile apparatus of cardiac myocytes.

  • It is a distinctive cardiac necrosis marker for triaging chest pain patients.
  • It outperforms existing hs-Troponin assays for early Rule-out of Myocardial Infarction.
  • The cMyC Algorithm reduces patients in observation groups[ref] => Cost saving for hospitals.
  • It is suitable as a POC assay as analytical sensitivity is less critical (requires 10 ng/L LOD).
  • cMyC rises faster to detectable levels compared to troponin.
  • cMyC release following cardiac surgical interventions show similar release patterns as Troponin but rises faster to detectable levels.